annual FCF:
$142.30M-$75.11M(-34.55%)Summary
- As of today (May 29, 2025), RDY annual free cash flow is $142.30 million, with the most recent change of -$75.11 million (-34.55%) on March 1, 2025.
- During the last 3 years, RDY annual FCF has risen by +$20.69 million (+17.01%).
- RDY annual FCF is now -71.48% below its all-time high of $499.02 million, reached on March 31, 2023.
Performance
RDY Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$127.15M+$153.52M(+582.04%)Summary
- As of today (May 29, 2025), RDY quarterly free cash flow is $127.15 million, with the most recent change of +$153.52 million (+582.04%) on March 1, 2025.
- Over the past year, RDY quarterly FCF has increased by +$63.00 million (+98.20%).
- RDY quarterly FCF is now -47.92% below its all-time high of $244.12 million, reached on December 31, 2022.
Performance
RDY quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$142.30M+$63.00M(+79.44%)Summary
- As of today (May 29, 2025), RDY TTM free cash flow is $142.30 million, with the most recent change of +$63.00 million (+79.44%) on March 1, 2025.
- Over the past year, RDY TTM FCF has dropped by -$75.11 million (-34.55%).
- RDY TTM FCF is now -76.59% below its all-time high of $607.94 million, reached on September 30, 2023.
Performance
RDY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
RDY Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | +98.2% | -34.5% |
| 3 y3 years | +17.0% | +85.1% | +17.0% |
| 5 y5 years | -57.4% | +1564.1% | -57.4% |
RDY Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.5% | +17.0% | -47.9% | +582.0% | -76.6% | +79.4% |
| 5 y | 5-year | -71.5% | +17.0% | -47.9% | +238.2% | -76.6% | +885.4% |
| alltime | all time | -71.5% | +149.0% | -47.9% | +135.4% | -76.6% | +144.1% |
RDY Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $142.30M(-34.5%) | $127.15M(-582.0%) | $142.30M(+79.4%) |
| Dec 2024 | - | -$26.38M(-258.0%) | $79.30M(-21.4%) |
| Sep 2024 | - | $16.69M(-32.8%) | $100.92M(-60.2%) |
| Jun 2024 | - | $24.84M(-61.3%) | $253.46M(+16.6%) |
| Mar 2024 | $217.41M(-56.4%) | $64.15M(-1447.1%) | $217.41M(-39.5%) |
| Dec 2023 | - | -$4.76M(-102.8%) | $359.06M(-40.9%) |
| Sep 2023 | - | $169.23M(-1609.6%) | $607.94M(+18.2%) |
| Jun 2023 | - | -$11.21M(-105.4%) | $514.18M(+3.0%) |
| Mar 2023 | $499.02M(+310.3%) | $205.80M(-15.7%) | $499.02M(+37.9%) |
| Dec 2022 | - | $244.12M(+223.4%) | $361.90M(+24.5%) |
| Sep 2022 | - | $75.47M(-386.1%) | $290.69M(+55.3%) |
| Jun 2022 | - | -$26.38M(-138.4%) | $187.24M(+54.0%) |
| Mar 2022 | $121.61M(-60.9%) | $68.69M(-60.3%) | $121.61M(-24.1%) |
| Dec 2021 | - | $172.90M(-718.1%) | $160.20M(-984.2%) |
| Sep 2021 | - | -$27.97M(-69.6%) | -$18.12M(-118.0%) |
| Jun 2021 | - | -$92.00M(-185.8%) | $100.74M(-67.6%) |
| Mar 2021 | $311.16M(-6.9%) | $107.28M(-2079.2%) | $311.16M(+47.1%) |
| Dec 2020 | - | -$5.42M(-106.0%) | $211.52M(-29.0%) |
| Sep 2020 | - | $90.88M(-23.3%) | $298.09M(-10.2%) |
| Jun 2020 | - | $118.42M(+1449.9%) | $332.05M(-0.6%) |
| Mar 2020 | $334.10M(+15.0%) | $7.64M(-90.6%) | $334.10M(-16.0%) |
| Dec 2019 | - | $81.15M(-35.0%) | $397.80M(-23.2%) |
| Sep 2019 | - | $124.84M(+3.6%) | $517.92M(-1.1%) |
| Jun 2019 | - | $120.47M(+68.9%) | $523.45M(+80.1%) |
| Mar 2019 | $290.59M(+168.2%) | $71.34M(-64.6%) | $290.59M(+2.5%) |
| Dec 2018 | - | $201.27M(+54.4%) | $283.53M(+92.9%) |
| Sep 2018 | - | $130.38M(-216.0%) | $147.00M(+111.9%) |
| Jun 2018 | - | -$112.39M(-274.9%) | $69.37M(-36.0%) |
| Mar 2018 | $108.36M(-137.3%) | $64.28M(-0.7%) | $108.36M(-9.1%) |
| Dec 2017 | - | $64.74M(+22.8%) | $119.22M(+34.1%) |
| Sep 2017 | - | $52.74M(-171.9%) | $88.91M(-127.5%) |
| Jun 2017 | - | -$73.40M(-197.7%) | -$322.77M(+11.2%) |
| Mar 2017 | -$290.36M(-172.0%) | $75.14M(+118.2%) | -$290.36M(+5.2%) |
| Dec 2016 | - | $34.43M(-109.6%) | -$276.00M(+34.7%) |
| Sep 2016 | - | -$358.94M(+775.5%) | -$204.96M(-175.7%) |
| Jun 2016 | - | -$41.00M(-145.8%) | $270.69M(-32.9%) |
| Mar 2016 | $403.14M(+153.9%) | $89.50M(-15.1%) | $403.14M(-7.8%) |
| Dec 2015 | - | $105.47M(-9.6%) | $437.17M(+48.7%) |
| Sep 2015 | - | $116.72M(+27.6%) | $293.96M(+39.1%) |
| Jun 2015 | - | $91.45M(-26.0%) | $211.32M(+33.1%) |
| Mar 2015 | $158.78M(+8.3%) | $123.53M(-427.3%) | $158.78M(+16.5%) |
| Dec 2014 | - | -$37.74M(-210.8%) | $136.27M(-40.5%) |
| Sep 2014 | - | $34.07M(-12.5%) | $228.86M(+60.6%) |
| Jun 2014 | - | $38.92M(-61.5%) | $142.52M(-2.8%) |
| Mar 2014 | $146.64M(+33.3%) | $101.01M(+84.1%) | $146.64M(+166.0%) |
| Dec 2013 | - | $54.86M(-204.9%) | $55.14M(+51.7%) |
| Sep 2013 | - | -$52.27M(-221.4%) | $36.35M(-68.7%) |
| Jun 2013 | - | $43.05M(+353.0%) | $116.31M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | $110.05M(-30.6%) | $9.50M(-73.7%) | $110.05M(-47.3%) |
| Dec 2012 | - | $36.08M(+30.3%) | $208.64M(-15.1%) |
| Sep 2012 | - | $27.68M(-24.8%) | $245.63M(+18.7%) |
| Jun 2012 | - | $36.78M(-66.0%) | $206.90M(+30.5%) |
| Mar 2012 | $158.54M(-300.7%) | $108.10M(+47.9%) | $158.54M(+783.6%) |
| Dec 2011 | - | $73.07M(-760.8%) | $17.94M(-121.0%) |
| Sep 2011 | - | -$11.06M(-4.5%) | -$85.34M(+25.9%) |
| Jun 2011 | - | -$11.57M(-64.4%) | -$67.80M(-14.2%) |
| Mar 2011 | -$79.01M(-141.8%) | -$32.50M(+7.6%) | -$79.01M(+50.6%) |
| Dec 2010 | - | -$30.21M(-565.9%) | -$52.45M(-316.0%) |
| Sep 2010 | - | $6.48M(-128.5%) | $24.28M(-72.0%) |
| Jun 2010 | - | -$22.78M(+283.9%) | $86.80M(-54.0%) |
| Mar 2010 | $188.81M(-3484.9%) | -$5.94M(-112.8%) | $188.81M(-34.0%) |
| Dec 2009 | - | $46.51M(-32.6%) | $286.20M(+35.6%) |
| Sep 2009 | - | $69.00M(-12.9%) | $211.09M(+147.7%) |
| Jun 2009 | - | $79.23M(-13.4%) | $85.23M(-1627.9%) |
| Mar 2009 | -$5.58M(+42.4%) | $91.45M(-419.8%) | -$5.58M(-93.6%) |
| Dec 2008 | - | -$28.60M(-49.7%) | -$86.91M(+32.2%) |
| Sep 2008 | - | -$56.86M(+391.4%) | -$65.75M(+39.3%) |
| Jun 2008 | - | -$11.57M(-214.3%) | -$47.19M(+1104.4%) |
| Mar 2008 | -$3.92M(-102.5%) | $10.12M(-236.1%) | -$3.92M(-105.3%) |
| Dec 2007 | - | -$7.44M(-80.6%) | $74.25M(-45.7%) |
| Sep 2007 | - | -$38.30M(-220.8%) | $136.77M(-40.4%) |
| Jun 2007 | - | $31.70M(-64.1%) | $229.62M(+46.0%) |
| Mar 2007 | $157.24M(-2647.6%) | $88.29M(+60.3%) | $157.24M(+168.8%) |
| Dec 2006 | - | $55.09M(+1.0%) | $58.49M(+460.5%) |
| Sep 2006 | - | $54.54M(-234.1%) | $10.43M(-123.3%) |
| Jun 2006 | - | -$40.68M(+288.9%) | -$44.72M(+624.6%) |
| Mar 2006 | -$6.17M(-150.9%) | -$10.46M(-248.8%) | -$6.17M(-114.8%) |
| Dec 2005 | - | $7.03M(-1244.5%) | $41.60M(+125.4%) |
| Sep 2005 | - | -$614.50K(-71.1%) | $18.46M(+14.3%) |
| Jun 2005 | - | -$2.13M(-105.7%) | $16.15M(+33.3%) |
| Mar 2005 | $12.11M(-64.9%) | $37.31M(-331.6%) | $12.11M(-182.8%) |
| Dec 2004 | - | -$16.11M(+451.6%) | -$14.63M(-271.1%) |
| Sep 2004 | - | -$2.92M(-52.6%) | $8.55M(-57.8%) |
| Jun 2004 | - | -$6.17M(-158.3%) | $20.27M(-41.3%) |
| Mar 2004 | $34.56M(-41.1%) | $10.57M(+49.5%) | $34.56M(+7.3%) |
| Dec 2003 | - | $7.07M(-19.7%) | $32.21M(-9.5%) |
| Sep 2003 | - | $8.80M(+8.5%) | $35.59M(+0.1%) |
| Jun 2003 | - | $8.12M(-1.2%) | $35.55M(-39.4%) |
| Mar 2003 | $58.70M(-21.2%) | $8.22M(-21.4%) | $58.70M(-26.8%) |
| Dec 2002 | - | $10.45M(+19.3%) | $80.16M(-23.3%) |
| Sep 2002 | - | $8.76M(-72.0%) | $104.55M(+5.8%) |
| Jun 2002 | - | $31.27M(+5.4%) | $98.83M(+32.7%) |
| Mar 2002 | $74.50M(+2568.2%) | $29.67M(-14.8%) | $74.50M(+66.2%) |
| Dec 2001 | - | $34.84M(+1044.3%) | $44.83M(+348.8%) |
| Sep 2001 | - | $3.04M(-56.2%) | $9.99M(+43.8%) |
| Jun 2001 | - | $6.94M | $6.94M |
| Mar 2001 | $2.79M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual free cash flow?
- What is the all time high annual FCF for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual FCF year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly FCF year-on-year change?
- What is Dr Reddys Laboratories Limited TTM free cash flow?
- What is the all time high TTM FCF for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM FCF year-on-year change?
What is Dr Reddys Laboratories Limited annual free cash flow?
The current annual FCF of RDY is $142.30M
What is the all time high annual FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual free cash flow is $499.02M
What is Dr Reddys Laboratories Limited annual FCF year-on-year change?
Over the past year, RDY annual free cash flow has changed by -$75.11M (-34.55%)
What is Dr Reddys Laboratories Limited quarterly free cash flow?
The current quarterly FCF of RDY is $127.15M
What is the all time high quarterly FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly free cash flow is $244.12M
What is Dr Reddys Laboratories Limited quarterly FCF year-on-year change?
Over the past year, RDY quarterly free cash flow has changed by +$63.00M (+98.20%)
What is Dr Reddys Laboratories Limited TTM free cash flow?
The current TTM FCF of RDY is $142.30M
What is the all time high TTM FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM free cash flow is $607.94M
What is Dr Reddys Laboratories Limited TTM FCF year-on-year change?
Over the past year, RDY TTM free cash flow has changed by -$75.11M (-34.55%)